ArticleJournal of chemical information and modeling2025
Binding of Antimicrobial Peptide Indolicidin to DMPC Bilayer Using Replica-Exchange Molecular Dynamics.
Article in Journal of chemical information and modeling, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Deep Learning Enables Identification of Antimicrobial Peptides Through Mechanochromic Fingerprints.Angewandte Chemie (International ed. in English) · 2026Article
- Identification of potential biomarkers of tryptophan metabolism in Kawasaki disease and exploration of potential mechanisms.Translational pediatrics · 2026Article
- Dual-pore size covalent organic frameworks shelled magnetic particles for anti-microbial peptide and microprotein enrichment with simultaneous exclusion of large proteins.Mikrochimica acta · 2026Article
- Nanosystems for delivery of indolicidin peptide.Frontiers in medical technology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cationic antimicrobial peptides (AMPs) are toxic to microbes, such as bacteria and fungi, and have been increasingly studied as an alternative to traditional antibiotics, in part because AMPs are bactericidal with a minimum risk of developing bacterial resistance. Indolicidin (IL) is an AMP derived from bovine neutrophils that is unique due to its high prevalence of tryptophan and proline amino acids and its disordered structure. In addition to its antimicrobial activity, IL has exhibited toxicity toward mammalian cells, resulting in hemolysis. Although the precise physicochemical mechanism of IL cytotoxicity is unknown, its interactions with lipid bilayers are the primary focus of investigation. We conducted all-atom replica-exchange molecular dynamics simulations with solute tempering (REST) to rigorously explore the interactions between IL and a dimyristoylphosphatidylcholine (DMPC) bilayer and establish the atomistic basis of IL binding. We also performed REST simulations of IL in water to probe the conformational changes in IL between water and bilayer environments. Our simulations demonstrate that IL, which predominantly adopts random coil conformations in both environments, loses turn structure and tertiary contacts, extending upon binding to the bilayer. IL interactions with the bilayer are stabilized by its positively charged C-terminus, which features two arginines that anchor to the bilayer and coordinate lipid phosphate groups. When IL binds to the bilayer, it largely resides in the interfacial region and its adsorption to the bilayer results in peptide desolvation. IL depletes the lipid density in its binding footprint, disrupting fatty acid tails of nearby lipids. These results are highlighted by a bilayer-aware clustering analysis, which shows that IL adopts dominant inserted and partially surface-bound states. We demonstrate that our simulation results are in good agreement with the available experimental data. Consequently, our simulations provide a complementary view of binding of IL to lipid bilayers that further elucidates its molecular mechanism.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.